Tag Archives: Research and development

ITALY – Modena. New Stem Cell Research Center Opens. Berlusconi: “Brain Drain” is a Myth

Image via Wikipedia

One of the most advanced research centers for the therapeutic applications of epithelial stem cells in the world, the ‘Stefano Ferrari’ regenerative medicine center at the University of Modena and Reggio Emilia, opened its doors with the ambitious goal of becoming the flagship research center in Italy. It was completely financed by the Modena Savings Bank, which invested 13 million euros for its completion and was inaugurated by Welfare Minister Maurizio Sacconi and Emilia-Romagna President Vasco Errani. It includes a new three floor, 30,000 square meter building (half of which is contamination controlled) at
Read More…

BioTime Commences Shipment of Stem Cell Research Products to Millipore

Image via Wikipedia

BioTime Inc.announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks. Derived from human embryonic stem cells but not fully differentiated into specific cell types, each ACTCellerate™ line provides a convenient, highly purified source of progenitor cells that may
Read More…

International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program

International Stem Cell Corporation announced that its Research and Development team has advanced its program to create a functional and transplantable human cornea by developing a new method to derive corneal endothelium-like cells from human pluripotent stem cells.

This work represents a significant step towards the creation of complete cornea tissue that can be used for transplantation and supports prior data showing indications of corneal endothelium generated by ISCO’s collaborators at Sankara Nethralaya Eye Hospital, India. Such cells by themselves may potentially promote wound healing and regeneration of the cornea and therefore could be used as a standalone medical treatment.

Read More…